|
(b)(4).Internal file number - (b)(4): during processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for evaluation.The reported patient effect of myocardial infarction is listed in the xience alpine everolimus eluting coronary stent system, instructions for use as known patient effects.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
It was reported that on (b)(6) 2018, a 3.5 x 28 mm xience alpine stent was implanted for treatment in a lesion of an unspecified vessel.On (b)(6) 2018, the patient was re-hospitalized for acute myocardial infarction (mi) and other cardiovascular (cv) symptoms.Unspecified treatment was administered and the final patient outcome is reportedly unknown.No additional information was provided.
|